| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 3.726 | 37.282 | 33.010 | 32.561 | 43.421 | 90.959 | 104.454 | 78.118 |
| Total Income - EUR | - | 0 | 14.067 | 52.828 | 46.033 | 38.455 | 48.293 | 96.132 | 109.198 | 83.700 |
| Total Expenses - EUR | - | 251 | 13.889 | 37.163 | 41.130 | 41.639 | 52.881 | 91.364 | 102.964 | 89.839 |
| Gross Profit/Loss - EUR | - | -251 | 178 | 15.665 | 4.903 | -3.184 | -4.588 | 4.768 | 6.234 | -6.140 |
| Net Profit/Loss - EUR | - | -251 | 142 | 15.295 | 4.573 | -3.316 | -5.014 | 4.114 | 5.250 | -8.510 |
| Employees | - | 0 | 1 | 2 | 2 | 1 | 2 | 4 | 5 | 3 |
Check the financial reports for the company - Ninmedactiv S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 28 | 41.594 | 42.160 | 33.815 | 27.143 | 19.914 | 14.911 | 9.385 | 5.291 |
| Current Assets | - | 749 | 21.934 | 23.170 | 22.647 | 14.278 | 6.690 | 6.015 | 9.215 | 5.502 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 58 | 0 | 0 |
| Receivables | - | 705 | 20.866 | 20.483 | 20.546 | 249 | 1.386 | 1.727 | 4.025 | 9 |
| Cash | - | 45 | 1.067 | 2.687 | 2.102 | 14.028 | 5.304 | 4.230 | 5.189 | 5.493 |
| Shareholders Funds | - | -206 | -61 | 15.235 | 19.513 | 13.848 | 15 | 1.995 | 5.298 | -3.276 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 984 | 4.376 | 7.515 | 8.214 | 5.277 | 9.657 | 7.119 | 6.248 | 11.751 |
| Income in Advance | - | 0 | 59.213 | 42.580 | 28.736 | 22.297 | 16.932 | 11.812 | 7.053 | 2.318 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Ninmedactiv S.r.l.